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1. Introduction 
Most eukaryotic mRNAs contain a cap structure 
m’GpppX(m) at their 5’.termini. Many attempts have 
been made to elucidate the biological significance of 
this modified structure. The cap-carrying mRNA 
shows higher translation efficiency in protein syn- 
thesis than the cap-deleted mRNA [l-3]. Capped 
mRNA binds to ribosomes more efficiently than the 
decapped one. 
The cap structure stabilizes eukaryotic mRNA 
against degradation by S’exonucleases. The capped 
mRNA is more stable than the unblocked one when 
mRNA is injected into Xenopus luevis oocytes or 
incubated with extracts of wheat germ, mouse L cell 
and Sacchuromyces cerevisiae [ 1,3,4]. These results 
suggest that the unblocked mRNA is degraded from 
the 5’.terminus exonucleolytically, while the capped 
mRNA is not degraded by exonuclease. 5’.Exonucle- 
ase has been obtained from the supernatant fraction 
of wheat germ extract [S]. The enzyme digests an 
unblocked mRNA from the 5’.terminus to release 
5’.mononucleotides, but it is not able to hydrolyze 
both the 5’.capped mRNA and the 5’.OH mRNA 
without free phosphates at the 5’.terminus. A 5’.exo- 
nuclease has been purified also from Saccharomyces 
cerevisiae [4]. However, stability of mRNA may be 
different in various kinds of cell, depending on the 
relative contents of the enzymes digesting mRNA. 
Such difference in mRNA stability is especially 
expected between a highly differentiated cell and a 
cell carrying a possibility of further differentiation, as 
sometimes the former has lost a nucleus or its func- 
tion including transcriptional machinery during dif- 
ferentiation. 
hedrosis virus (CPV) was incubated with the extracts 
prepared from various kinds of cell under the condi- 
tion of protein synthesis. Depending on the kind of 
cell, there are two types of degradation of an mRNA. 
In the extract of highly differentiated cells such as 
reticulocyte and muscle, the 5’.capped mRNA is 
degraded at similar ate as the cap-deleted mRNA. In 
the extract of a cell carrying a possibility of further 
differentiation such as erythroblast, BHK cell (cul- 
tured cell), and wheat germ, the decapped mRNA is 
degraded more rapidly than the 5’.capped one. This 
difference seems to be mainly dependent on the activ- 
ity of 5’.exonuclease in a cell. 
2. Materials and methods 
The radioisotopically abeled CPV mRNA was pre- 
pared in vitro as in [ 1,6]. To delete the 5’.capped 
structure without degradation of RNA chain, mRNA 
was hydrolyzed with tobacco phosphodiesterase s 
in [7]. 
[3H]Uracil-labeled mRNA of cytoplasmic poly- 
Bone marrow cells were prepared from New Zealand 
White rabbits made anemic by subcutaneous injection 
of 5 mg acetylphenylhydrazine/kg. The erythroblasts 
were separated from the other nucleated cells as in 
[8] by centrifugation 3 times through solution of 
bovine serum albumin (fraction V) at different densi- 
ties. Of the prepared cells >90% were found to be 
erythroblasts in the various tages of maturation by 
Wright-Giemsa taining [8]. Reticulocytes were col- 
lected from the peripheral blood of these anemic rab- 
bits. Lysates of reticulocyte and erythroblast were 
prepared as in [9]. Wheat germ extract was prepared 
asin [l]. 
To assay the rate of degradation of mRNA, CPV 
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mRNA labeled with [3H]UTP (5 X 10’ cpm) was 
added to the cell lysate which was adjusted to the 
condition used for in vitro protein synthesis. After 
the mixture was incubated at 30°C for the indicated 
time, trichloroacetic acid solution was added to 5% 
finally in the ice cold bath. Radioactivity in the result- 
ing precipitate was measured as in [3]. Degradation of 
the 5’4erminal labeled CPV mRNA after incubation 
in erythroblast lysate was analyzed by centrifugation 
in glycerol density gradient as in [ 11. Muscle extract 
was prepared as in [lo], liver extract as in [ 111 and 
BHK cell extract as in [ 121. 
Degradation products of the unblocked mRNA by 
incubation in erythroblast lysate were analyzed by 
DEAE-cellulose chromatography with 7 M urea con- 
taining salt solution as in [ 131. 
3. Results and discussion 
In wheat germ extract CPV mRNA with capped 
5’4erminus is more stable than decapped mRNA, 
which is prepared by treatment with the pyrophos- 
phatase purified from cultured tobacco cells (fig.la). 
The cap structure protects mRNA from 5’-exonucle- 
ase attack and consequently stabilizes it in wheat 
germ or in Xenopus oocyte [ 1,3]. However, we could 
not detect any significant difference in the stability 
between the capped and the decapped mRNAs in 
reticulocyte lysate (figlb). Similar results were 
obtained in [3]. We next compared results obtained 
from reticulocytes with those from erythroblasts, 
which are in the younger stage of erythroid cell matu- 
ration. Erythroblast-rich fraction was isolated from 
rabbit bone marrow by the same procedure as used 
for isolation of reticulocytes and the stability of 
mRNA was examined. We call the lysate of the frac- 
tion the ‘erythroblast lysate’. In the erythroblast 
lysate, CPV mRNA with the capped 5’4erminus was 
clearly more stable than the decapped one (fig.1~). 
This result suggests that the unblocked mRNA is 
degraded by exonuclease attack from the 5’4erminus. 
Degradation process of CPV mRNA in erythro- 
blast lysate was then analyzed by sedimentation in a 
glycerol density gradient. CPV mRNA labeled at its 
5’-terminus by [methyL3H] SAM was incubated with 
erythroblast lysate under the conditions, in which the 
in vitro protein synthesis is carried out. After 30 s 
incubation at 30°C degradation products were ana- 
lyzed with centrifugation in a glycerol density gradi- 
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Fig.1. Degradation of CPV mRNA in wheat germ extract, 
reticulocyte lysate and erythroblast lysate. CPV mRNA 
labeled internally with [3H]UTP (1.5 X lOa cpm/pg, 5 X lOa 
cpm) was incubated at 30°C in a reaction mixture used for in 
vitro protein synthesis. (a) Wheat germ extract: the reaction 
mixture (50 ~1) contained 20 mM Hepes buffer (pH 7.6), 
2.5 mM magnesium acetate, 100 mM KCl, 4 mM dithiothrei- 
tol, 1 mM ATP, 20 PM GTP, 8 mM creatine phosphate, 2 r.rg 
creatine phosphate kinase and 3 PM each of 20 amino acids. 
(b) Reticulocyte lysate: the mixture contained 12 mM Hepes 
buffer (pH 7.5), 7.5 mM KCl, 1.5 mM magnesium acetate, 
0.8 mM ATP, 0.16 mM GTP, 10 mM creatine phosphate, 
11 c(g creatine phosphate kinase, 5 mM dithiothreitol, 0.1 mM 
each of 20 amino acids and 20 rg/ml haemin. (c) Erythro- 
blast lysate: same conditions as in (b). After incubation, radio- 
active polynucleotides precipitated in 5% trichloroacetic acid 
were collected on a nitrocellulose filter, and radioactivity 
was counted in toiuene-based scintillant: (o-o) capped 
mRNA; (o---e) decapped mRNA. 
ent (fig.2). A large proportion of the 5’-capped CPV 
mRNA did not change in size, whereas the decapped 
CPV mRNA labeled at its 5’-terminus with [T-~~P]- 
ATP was immediately degraded during incubation in 
the lysate. The degradation product was analyzed by 
DEAEcellulose/7 M urea chromatography to deter- 
mine the product sizes. The radioactivity of the 
degradation product was detected only in the mono- 
nucleotide fraction, but not in oligonucleotide frac- 
tions (fig.3). These results suggest he presence of 
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Fig.2. Stability of CPV mRNA during incubation with the 
erythroblast lysate. CPV mRNA labeled with [methyl-sH]- 
SAM (a) and unblocked CPV mRNA Labeled at the 5’-ter- 
minus with [r-saP]ATP (b) were incubated with the S-30 
fraction obtained from erythroblasts in 100 ~1 of a reaction 
mixture in erythroblasts at 30°C for 30 s. After incubation, 
100 ~1 water-saturated phenol was added and mixture was 
shaken immediately. The aqueous phase was applied on a 
glycerol density gradient (10-30s) in 20 mM EDTA/50 mM 
sodium acetate (pH 5.5) and centrifuged at 38 000 rev./min 
for 15 h in a SW40 swinging bucket rotor in Beckman-Spinco 
ultracentrifuge. Fractions (0.28 ml) were collected from the 
bottom of the tube, and the radioactivity was counted in 
Kinard’s scintillation fluid: (o---e) no incubation; (o-o) 
incubation for 30 s. 
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rrg.4. Degradation of CPV mRNA in extracts from muscle, 
liver and BHK cell. The experimental conditions were as in 
fig.1 except for the reaction mixture. (a) Muscle extract: the 
reaction mixture (50 ~1) contained 0.15 M KCl, 0.01 M 
MgCl,, 6 mM p-mercaptoethanol, 0.01 M Tris-HCl buffer 
(pH 7.4). 2 mM ATP, 0.5 mM GTP, 10 mM phosphoenol 
pyruvate, 0.5 PM each of 20 amino acids and 2.5 r.rg pyruvate 
kinase. (b) Liver extract: the reaction mixture (50 ~1) con- 
tained 35 mM KCl, 3.5 mM MgCl,, 1 mM dithiothreitol, 
35 mM Tris-HCl (pH 7.5) 0.17 mM GTP, 0.7 mM ATP, 
7 mM creatine phosphate, 0.035 mM each of 20 amino acids 
and 2 r.rg creatine phosphate kinase. (c) BHK cell extract: the 
reaction mixture (50 ~1) contained 120 mM KCl, 5 mM mag- 
nesium acetate, 20 mM Hepes-KOH (pH 7.6), 6 mM p-mer- 
captoethanol, 1 mM ATP, 0.2 mM GTP, 0.1 mM each of 
20 amino acids, 10 mM creatine phosphate and 10 fig crea- 
tine phospho kinase: (o-o) capped mRNA; (e---o) 
decapped mRNA. 
Fig.3. DEAE-urea column chromatography of degradation 
products from the incubation of the unblocked mRNA (frac- 
tion 43-46, fig.2b) in the erythroblast extract. The sample 
solution was applied to a column (diam. 0.6 cm X length 
40 cm) of DEAE-cellulose (Whatman DE-l). Elution was car- 
ried out with a linear gradient from O-O.25 M NaCl(lO0 ml) 
in 7 M urea, 0.02 M Tris-HCl buffer (pH 7.6): (o---o) 
sample; (e-o) pancreatic RNase A digest of ribosomal 
RNA as a size marker. 
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exonuclease activity in the erytbroblast-rich fraction. 
It seems that this exonuclease cleaves the decapped 
mRNA progressively in the direction from 5’-3’- 
terminus as the 5’-exonuclease activity found in 
wheat germ extract [5]. In rabbit reticulocyte lysate, 
the exonuclease activity may be overcome by endo- 
nuclease activity or be repressed, or the exonuclease 
may not be contained. 
As a comparison, the stability of mRNAs, either 
with or without the 5’-cap structure, was also assayed 
in cell lysates prepared from various kinds of tissues. 
When CPV mRNA was added to the cell-free system 
obtained from muscle, the mode of degradation of
mRNA carrying the cap was the same as the decapped 
one (fig.4a). As degradation of either mRNA with or 
without a cap proceeds very slowly, nuclease activity 
in muscle tissue may be low. The mRNAs added to the 
cell-free system from the liver were degraded rapidly 
in both the cases of capped and decapped mRNAs as 
shown in figAb. Although the amounts of proteins in 
muscle xtract and liver extract (fig.4) were made 
equal, mRNA degradation i liver extract was 
rapid compared with the case of muscle xtract. 
Nuclease activity is very strong in liver cells. In an in 
vitro system of BHK cell, which is a cell line estab- 
lished from baby hamster kidney, the mode of degra- 
dation of the decapped mRNA was different from the 
capped one (figAc) as in erythroblasts. 
Summarizing these results, degradation modes of 
mRNA are classified into two types: 
(1) 
(2) 
Cap-carrying mRNA is degraded at the same rate 
as capdeleted mRNA, e.g., in the extracts of 
muscle, liver, and reticulocytes; 
Cap-deleted mRNA is degraded rapidly, while 
cap-carrying mRNA slowly, e.g., in the extracts 
of wheat germ, BHK cells, and erythroblasts. 
In (2), activity of the 5’-exonuclease in a cell is strong 
compared with endonuclease activity. Presence of the 
5’.cap structure must protect mRNA from exonucleo- 
lytic degradation. In the highly differentiated cells 
such as reticulocyte and muscle (l), the 5’-exonuclease 
seems to be repressed or lost during differentiation. 
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